Healthcare & Life Sciences

Restore Medical

series-b
series-b
Stage
1
Investors

About

Restore Medical is an Israeli medical device company developing the ContraBand™ system, a transcatheter pulmonary artery banding (PAB) catheter-delivered implant intended to treat patients with heart failure with reduced ejection fraction (HFrEF). The device is designed to improve left ventricular function and reduce mitral regurgitation in congestive heart failure patients.

Explore Restore Medical's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.